Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Not pending/lapsed |
21 | DE file number | DAKZ | 603 40 351.4 |
96 | EP file number | EAKZ | 03 75 4445.9 |
86 | WO file number | WAKZ | PCT/US03/27772 |
97 | EP publication number | EPN | 1608339 |
87 | WO publication number | WPN | 2004078161 |
54 | Designation/title | TI | PHARMAZEUTISCHE MISCHKRISTALLE VON CELECOXIB-NICOTINAMID |
51 | IPC main class | ICM (ICMV) | A61K 31/415 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 31/455 (2006.01) |
22 | DE application date | DAT | Sep 4, 2003 |
96 | EP application date | EAT | Sep 4, 2003 |
86 | WO application date | WAT | Sep 4, 2003 |
43 | Date of first publication | OT | Sep 16, 2004 |
| Date of publication of grant | PET | Mar 21, 2012 |
71/73 | Applicant/owner | INH | McNeil-PPC, Inc., Skillman, N.J., US; The Regents of the University of Michigan, Ann Arbor, Mich., US; University of South Florida, Tampa, Fla., US |
72 | Inventor | IN | BOURGHOL HICKEY, Magali, Medford, MA 02155, US; ALMARSSON, Örn, Shrewsbury, MA 01545, US; ZAWOROTKO, Michael, J., Tampa, FL 3362, US; PETERSON, Matthew, Framingham, MA 01701, US; RODRIGUEZ-HORNEDO, Nair, Ann Arbor, MI 48103, US; MOULTON, Brian, Providence, RI 02912, US |
74 | Representative | VTR | Kador & Partner PartG mbB Patentanwälte, 80469 München, DE |
| Address for service | | KADOR & PARTNER PartG mbB Patent- und Rechtsanwälte, 80469 München, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 451213 P Feb 28, 2003
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 463962 P Apr 18, 2003
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 378956 Mar 3, 2003
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 487064 P Jul 11, 2003
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR |
81 | Designated WO countries | WDS | LT, AL, LV, MK |
| Published EP/WO documents | EPWOPN | Original document:
EP000001608339 Searchable text:
EP000001608339 Original document:
EP000001608339B1 Searchable text:
EP000001608339B1 Original document:
WO002004078161 Searchable text:
WO002004078161 |
43 | Date of first publication | EVT | Sep 16, 2004 |
| Date of the first transfer into DPMAregister | EREGT | May 27, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Jun 24, 2021 (Show all update days)(Hide all update days)- Jun 24, 2021; May 18, 2021; Aug 27, 2019; Oct 10, 2018; Sep 27, 2018; Sep 6, 2018; Sep 12, 2017; Sep 13, 2016; Sep 15, 2015; Aug 25, 2015; Apr 21, 2015; Sep 10, 2014; Oct 8, 2013; Sep 25, 2013; Sep 7, 2013; Apr 18, 2013; Jan 27, 2013; Oct 9, 2012; Sep 6, 2012; Jun 12, 2012; Jun 5, 2012; May 16, 2012; May 4, 2012; May 3, 2012; Apr 13, 2012; Mar 29, 2012; Mar 22, 2012; Feb 11, 2012; Feb 4, 2012; Aug 23, 2011; May 31, 2011
- Historical data not available for this/these date(s)
- May 27, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 8)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 28, 2012 |
71/73 | Applicant/owner | INH | McNeill-PPC, Inc., Skillman, N.J., US; The Regents of the University of Michigan, Ann Arbor, Mich., US; University of South Florida, Tampa, Fla., US |
71/73 | Previous applicant/owner | INHF | Transform Pharmaceuticals, Inc., Lexington, Mass., US, University of South Florida, Tampa, Fla., US, The Regents of the University of Michigan, Ann Arbor, Mich., US |